PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Inclusion Criteria:

• Patients with AMD related lesions:

Newly diagnosed (up to 6 months) non-treated CNV patients secondary to AMD in the study eye, or GA patients or Early and Intermediate AMD patients.

• Age ³ 50 for AMD patients
• VA with habitual correction in study eye 6/60 or better
• Mental and physical ability to perform a PHP/HPHP test
• Subject able and willing to sign consent form and participate in study
• Subject is not participating in another study when conducting the test

Exclusion Criteria:

• Evidence of macular disease other than AMD or Glaucoma in the study eye.

  • Presence of any significant media opacity that precludes a clear view of the macular area as identified by biomicroscopy, fundus photography, or fluorescein angiography in the study eye
  • Any non-macular related ocular surgery performed within 3 months prior to the study in the study eye
  • CNV patient inability to tolerate intravenous fluorescein angiography